Industry Research Reports
Home > Reports > Chemical & Material > Sofosbuvir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Sofosbuvir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-01-16
Pages: 125 Pages
Report ld: 3565593
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Sofosbuvir API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Sofosbuvir(CAS：1190307-88-0) is a medication used to treat hepatitis C.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sofosbuvir API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sofosbuvir API by region & country, by Type, and by Application.
The Sofosbuvir API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sofosbuvir API.
MARKET SEGMENTATION
By Company
- Mylan
- Teva
- Century Pharmaceuticals
- Beijing Huikang Boyuan Chemical Tech Co.,Ltd
- Fuxin Long Rui Pharmaceutical
- Alembic Pharmaceuticals Limited
- Hetero Drugs
- Jiangsu Yutian Pharmaceutical
- Aspire Lifesciences Pvt Ltd
- Haoyuan Chemexpress Co.Ltd
- CHEMO
- Hanways Chempharm Co., Limited
- Guangzhou Tosun Pharmaceutical
- CAD Middle East Pharmaceutical Industries LLC
- Srini Pharmaceuticals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Above 98 %
- Above 99 %
Segment by Application
- Tablets
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sofosbuvir API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sofosbuvir API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sofosbuvir API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Sofosbuvir API Product Introduction
1.2 Global Sofosbuvir API Market Size Forecast
1.2.1 Global Sofosbuvir API Sales Value (2020-2031)
1.2.2 Global Sofosbuvir API Sales Volume (2020-2031)
1.2.3 Global Sofosbuvir API Sales Price (2020-2031)
1.3 Sofosbuvir API Market Trends & Drivers
1.3.1 Sofosbuvir API Industry Trends
1.3.2 Sofosbuvir API Market Drivers & Opportunity
1.3.3 Sofosbuvir API Market Challenges
1.3.4 Sofosbuvir API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sofosbuvir API Players Revenue Ranking (2024)
2.2 Global Sofosbuvir API Revenue by Company (2020-2025)
2.3 Global Sofosbuvir API Players Sales Volume Ranking (2024)
2.4 Global Sofosbuvir API Sales Volume by Company Players (2020-2025)
2.5 Global Sofosbuvir API Average Price by Company (2020-2025)
2.6 Key Manufacturers Sofosbuvir API Manufacturing Base and Headquarters
2.7 Key Manufacturers Sofosbuvir API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sofosbuvir API
2.9 Sofosbuvir API Market Competitive Analysis
2.9.1 Sofosbuvir API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Sofosbuvir API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sofosbuvir API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Above 98 %
3.1.2 Above 99 %
3.2 Global Sofosbuvir API Sales Value by Type
3.2.1 Global Sofosbuvir API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Sofosbuvir API Sales Value, by Type (2020-2031)
3.2.3 Global Sofosbuvir API Sales Value, by Type (%) (2020-2031)
3.3 Global Sofosbuvir API Sales Volume by Type
3.3.1 Global Sofosbuvir API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Sofosbuvir API Sales Volume, by Type (2020-2031)
3.3.3 Global Sofosbuvir API Sales Volume, by Type (%) (2020-2031)
3.4 Global Sofosbuvir API Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablets
4.1.2 Others
4.2 Global Sofosbuvir API Sales Value by Application
4.2.1 Global Sofosbuvir API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Sofosbuvir API Sales Value, by Application (2020-2031)
4.2.3 Global Sofosbuvir API Sales Value, by Application (%) (2020-2031)
4.3 Global Sofosbuvir API Sales Volume by Application
4.3.1 Global Sofosbuvir API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Sofosbuvir API Sales Volume, by Application (2020-2031)
4.3.3 Global Sofosbuvir API Sales Volume, by Application (%) (2020-2031)
4.4 Global Sofosbuvir API Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Sofosbuvir API Sales Value by Region
5.1.1 Global Sofosbuvir API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Sofosbuvir API Sales Value by Region (2020-2025)
5.1.3 Global Sofosbuvir API Sales Value by Region (2026-2031)
5.1.4 Global Sofosbuvir API Sales Value by Region (%), (2020-2031)
5.2 Global Sofosbuvir API Sales Volume by Region
5.2.1 Global Sofosbuvir API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Sofosbuvir API Sales Volume by Region (2020-2025)
5.2.3 Global Sofosbuvir API Sales Volume by Region (2026-2031)
5.2.4 Global Sofosbuvir API Sales Volume by Region (%), (2020-2031)
5.3 Global Sofosbuvir API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Sofosbuvir API Sales Value, 2020-2031
5.4.2 North America Sofosbuvir API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Sofosbuvir API Sales Value, 2020-2031
5.5.2 Europe Sofosbuvir API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Sofosbuvir API Sales Value, 2020-2031
5.6.2 Asia Pacific Sofosbuvir API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Sofosbuvir API Sales Value, 2020-2031
5.7.2 South America Sofosbuvir API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sofosbuvir API Sales Value, 2020-2031
5.8.2 Middle East & Africa Sofosbuvir API Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sofosbuvir API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Sofosbuvir API Sales Value
6.2.1 Key Countries/Regions Sofosbuvir API Sales Value, 2020-2031
6.2.2 Key Countries/Regions Sofosbuvir API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Sofosbuvir API Sales Value, 2020-2031
6.3.2 United States Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Sofosbuvir API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Sofosbuvir API Sales Value, 2020-2031
6.4.2 Europe Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Sofosbuvir API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Sofosbuvir API Sales Value, 2020-2031
6.5.2 China Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
6.5.3 China Sofosbuvir API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Sofosbuvir API Sales Value, 2020-2031
6.6.2 Japan Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Sofosbuvir API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Sofosbuvir API Sales Value, 2020-2031
6.7.2 South Korea Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Sofosbuvir API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Sofosbuvir API Sales Value, 2020-2031
6.8.2 Southeast Asia Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Sofosbuvir API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Sofosbuvir API Sales Value, 2020-2031
6.9.2 India Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
6.9.3 India Sofosbuvir API Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Mylan
7.1.1 Mylan Company Information
7.1.2 Mylan Introduction and Business Overview
7.1.3 Mylan Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Mylan Sofosbuvir API Product Offerings
7.1.5 Mylan Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Introduction and Business Overview
7.2.3 Teva Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Teva Sofosbuvir API Product Offerings
7.2.5 Teva Recent Development
7.3 Century Pharmaceuticals
7.3.1 Century Pharmaceuticals Company Information
7.3.2 Century Pharmaceuticals Introduction and Business Overview
7.3.3 Century Pharmaceuticals Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Century Pharmaceuticals Sofosbuvir API Product Offerings
7.3.5 Century Pharmaceuticals Recent Development
7.4 Beijing Huikang Boyuan Chemical Tech Co.,Ltd
7.4.1 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Company Information
7.4.2 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Introduction and Business Overview
7.4.3 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Product Offerings
7.4.5 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Recent Development
7.5 Fuxin Long Rui Pharmaceutical
7.5.1 Fuxin Long Rui Pharmaceutical Company Information
7.5.2 Fuxin Long Rui Pharmaceutical Introduction and Business Overview
7.5.3 Fuxin Long Rui Pharmaceutical Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Fuxin Long Rui Pharmaceutical Sofosbuvir API Product Offerings
7.5.5 Fuxin Long Rui Pharmaceutical Recent Development
7.6 Alembic Pharmaceuticals Limited
7.6.1 Alembic Pharmaceuticals Limited Company Information
7.6.2 Alembic Pharmaceuticals Limited Introduction and Business Overview
7.6.3 Alembic Pharmaceuticals Limited Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Alembic Pharmaceuticals Limited Sofosbuvir API Product Offerings
7.6.5 Alembic Pharmaceuticals Limited Recent Development
7.7 Hetero Drugs
7.7.1 Hetero Drugs Company Information
7.7.2 Hetero Drugs Introduction and Business Overview
7.7.3 Hetero Drugs Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hetero Drugs Sofosbuvir API Product Offerings
7.7.5 Hetero Drugs Recent Development
7.8 Jiangsu Yutian Pharmaceutical
7.8.1 Jiangsu Yutian Pharmaceutical Company Information
7.8.2 Jiangsu Yutian Pharmaceutical Introduction and Business Overview
7.8.3 Jiangsu Yutian Pharmaceutical Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Jiangsu Yutian Pharmaceutical Sofosbuvir API Product Offerings
7.8.5 Jiangsu Yutian Pharmaceutical Recent Development
7.9 Aspire Lifesciences Pvt Ltd
7.9.1 Aspire Lifesciences Pvt Ltd Company Information
7.9.2 Aspire Lifesciences Pvt Ltd Introduction and Business Overview
7.9.3 Aspire Lifesciences Pvt Ltd Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Aspire Lifesciences Pvt Ltd Sofosbuvir API Product Offerings
7.9.5 Aspire Lifesciences Pvt Ltd Recent Development
7.10 Haoyuan Chemexpress Co.Ltd
7.10.1 Haoyuan Chemexpress Co.Ltd Company Information
7.10.2 Haoyuan Chemexpress Co.Ltd Introduction and Business Overview
7.10.3 Haoyuan Chemexpress Co.Ltd Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Haoyuan Chemexpress Co.Ltd Sofosbuvir API Product Offerings
7.10.5 Haoyuan Chemexpress Co.Ltd Recent Development
7.11 CHEMO
7.11.1 CHEMO Company Information
7.11.2 CHEMO Introduction and Business Overview
7.11.3 CHEMO Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 CHEMO Sofosbuvir API Product Offerings
7.11.5 CHEMO Recent Development
7.12 Hanways Chempharm Co., Limited
7.12.1 Hanways Chempharm Co., Limited Company Information
7.12.2 Hanways Chempharm Co., Limited Introduction and Business Overview
7.12.3 Hanways Chempharm Co., Limited Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Hanways Chempharm Co., Limited Sofosbuvir API Product Offerings
7.12.5 Hanways Chempharm Co., Limited Recent Development
7.13 Guangzhou Tosun Pharmaceutical
7.13.1 Guangzhou Tosun Pharmaceutical Company Information
7.13.2 Guangzhou Tosun Pharmaceutical Introduction and Business Overview
7.13.3 Guangzhou Tosun Pharmaceutical Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Guangzhou Tosun Pharmaceutical Sofosbuvir API Product Offerings
7.13.5 Guangzhou Tosun Pharmaceutical Recent Development
7.14 CAD Middle East Pharmaceutical Industries LLC
7.14.1 CAD Middle East Pharmaceutical Industries LLC Company Information
7.14.2 CAD Middle East Pharmaceutical Industries LLC Introduction and Business Overview
7.14.3 CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Product Offerings
7.14.5 CAD Middle East Pharmaceutical Industries LLC Recent Development
7.15 Srini Pharmaceuticals
7.15.1 Srini Pharmaceuticals Company Information
7.15.2 Srini Pharmaceuticals Introduction and Business Overview
7.15.3 Srini Pharmaceuticals Sofosbuvir API Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Srini Pharmaceuticals Sofosbuvir API Product Offerings
7.15.5 Srini Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Sofosbuvir API Industrial Chain
8.2 Sofosbuvir API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sofosbuvir API Sales Model
8.5.2 Sales Channel
8.5.3 Sofosbuvir API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Sofosbuvir API Market Trends
Table 2. Sofosbuvir API Market Drivers & Opportunity
Table 3. Sofosbuvir API Market Challenges
Table 4. Sofosbuvir API Market Restraints
Table 5. Global Sofosbuvir API Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Sofosbuvir API Revenue Market Share by Company (2020-2025)
Table 7. Global Sofosbuvir API Sales Volume by Company (2020-2025) & (Kg)
Table 8. Global Sofosbuvir API Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Sofosbuvir API Price by Company (2020-2025) & (US$/Kg)
Table 10. Key Manufacturers Sofosbuvir API Manufacturing Base and Headquarters
Table 11. Key Manufacturers Sofosbuvir API Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Sofosbuvir API
Table 13. Global Sofosbuvir API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sofosbuvir API as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Sofosbuvir API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Sofosbuvir API Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Sofosbuvir API Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Sofosbuvir API Sales Market Share in Value by Type (2020-2025)
Table 20. Global Sofosbuvir API Sales Market Share in Value by Type (2026-2031)
Table 21. Global Sofosbuvir API Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
Table 22. Global Sofosbuvir API Sales Volume by Type (2020-2025) & (Kg)
Table 23. Global Sofosbuvir API Sales Volume by Type (2026-2031) & (Kg)
Table 24. Global Sofosbuvir API Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Sofosbuvir API Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Sofosbuvir API Price by Type (2020-2025) & (US$/Kg)
Table 27. Global Sofosbuvir API Price by Type (2026-2031) & (US$/Kg)
Table 28. Global Sofosbuvir API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Sofosbuvir API Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Sofosbuvir API Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Sofosbuvir API Sales Market Share in Value by Application (2020-2025)
Table 32. Global Sofosbuvir API Sales Market Share in Value by Application (2026-2031)
Table 33. Global Sofosbuvir API Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
Table 34. Global Sofosbuvir API Sales Volume by Application (2020-2025) & (Kg)
Table 35. Global Sofosbuvir API Sales Volume by Application (2026-2031) & (Kg)
Table 36. Global Sofosbuvir API Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Sofosbuvir API Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Sofosbuvir API Price by Application (2020-2025) & (US$/Kg)
Table 39. Global Sofosbuvir API Price by Application (2026-2031) & (US$/Kg)
Table 40. Global Sofosbuvir API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Sofosbuvir API Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Sofosbuvir API Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Sofosbuvir API Sales Value by Region (2020-2025) & (%)
Table 44. Global Sofosbuvir API Sales Value by Region (2026-2031) & (%)
Table 45. Global Sofosbuvir API Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
Table 46. Global Sofosbuvir API Sales Volume by Region (2020-2025) & (Kg)
Table 47. Global Sofosbuvir API Sales Volume by Region (2026-2031) & (Kg)
Table 48. Global Sofosbuvir API Sales Volume by Region (2020-2025) & (%)
Table 49. Global Sofosbuvir API Sales Volume by Region (2026-2031) & (%)
Table 50. Global Sofosbuvir API Average Price by Region (2020-2025) & (US$/Kg)
Table 51. Global Sofosbuvir API Average Price by Region (2026-2031) & (US$/Kg)
Table 52. Key Countries/Regions Sofosbuvir API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Sofosbuvir API Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Sofosbuvir API Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Sofosbuvir API Sales Volume, (2020-2025) & (Kg)
Table 56. Key Countries/Regions Sofosbuvir API Sales Volume, (2026-2031) & (Kg)
Table 57. Mylan Company Information
Table 58. Mylan Introduction and Business Overview
Table 59. Mylan Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 60. Mylan Sofosbuvir API Product Offerings
Table 61. Mylan Recent Development
Table 62. Teva Company Information
Table 63. Teva Introduction and Business Overview
Table 64. Teva Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 65. Teva Sofosbuvir API Product Offerings
Table 66. Teva Recent Development
Table 67. Century Pharmaceuticals Company Information
Table 68. Century Pharmaceuticals Introduction and Business Overview
Table 69. Century Pharmaceuticals Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 70. Century Pharmaceuticals Sofosbuvir API Product Offerings
Table 71. Century Pharmaceuticals Recent Development
Table 72. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Company Information
Table 73. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Introduction and Business Overview
Table 74. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Product Offerings
Table 76. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Recent Development
Table 77. Fuxin Long Rui Pharmaceutical Company Information
Table 78. Fuxin Long Rui Pharmaceutical Introduction and Business Overview
Table 79. Fuxin Long Rui Pharmaceutical Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. Fuxin Long Rui Pharmaceutical Sofosbuvir API Product Offerings
Table 81. Fuxin Long Rui Pharmaceutical Recent Development
Table 82. Alembic Pharmaceuticals Limited Company Information
Table 83. Alembic Pharmaceuticals Limited Introduction and Business Overview
Table 84. Alembic Pharmaceuticals Limited Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Alembic Pharmaceuticals Limited Sofosbuvir API Product Offerings
Table 86. Alembic Pharmaceuticals Limited Recent Development
Table 87. Hetero Drugs Company Information
Table 88. Hetero Drugs Introduction and Business Overview
Table 89. Hetero Drugs Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Hetero Drugs Sofosbuvir API Product Offerings
Table 91. Hetero Drugs Recent Development
Table 92. Jiangsu Yutian Pharmaceutical Company Information
Table 93. Jiangsu Yutian Pharmaceutical Introduction and Business Overview
Table 94. Jiangsu Yutian Pharmaceutical Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95. Jiangsu Yutian Pharmaceutical Sofosbuvir API Product Offerings
Table 96. Jiangsu Yutian Pharmaceutical Recent Development
Table 97. Aspire Lifesciences Pvt Ltd Company Information
Table 98. Aspire Lifesciences Pvt Ltd Introduction and Business Overview
Table 99. Aspire Lifesciences Pvt Ltd Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100. Aspire Lifesciences Pvt Ltd Sofosbuvir API Product Offerings
Table 101. Aspire Lifesciences Pvt Ltd Recent Development
Table 102. Haoyuan Chemexpress Co.Ltd Company Information
Table 103. Haoyuan Chemexpress Co.Ltd Introduction and Business Overview
Table 104. Haoyuan Chemexpress Co.Ltd Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105. Haoyuan Chemexpress Co.Ltd Sofosbuvir API Product Offerings
Table 106. Haoyuan Chemexpress Co.Ltd Recent Development
Table 107. CHEMO Company Information
Table 108. CHEMO Introduction and Business Overview
Table 109. CHEMO Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 110. CHEMO Sofosbuvir API Product Offerings
Table 111. CHEMO Recent Development
Table 112. Hanways Chempharm Co., Limited Company Information
Table 113. Hanways Chempharm Co., Limited Introduction and Business Overview
Table 114. Hanways Chempharm Co., Limited Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 115. Hanways Chempharm Co., Limited Sofosbuvir API Product Offerings
Table 116. Hanways Chempharm Co., Limited Recent Development
Table 117. Guangzhou Tosun Pharmaceutical Company Information
Table 118. Guangzhou Tosun Pharmaceutical Introduction and Business Overview
Table 119. Guangzhou Tosun Pharmaceutical Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 120. Guangzhou Tosun Pharmaceutical Sofosbuvir API Product Offerings
Table 121. Guangzhou Tosun Pharmaceutical Recent Development
Table 122. CAD Middle East Pharmaceutical Industries LLC Company Information
Table 123. CAD Middle East Pharmaceutical Industries LLC Introduction and Business Overview
Table 124. CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 125. CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Product Offerings
Table 126. CAD Middle East Pharmaceutical Industries LLC Recent Development
Table 127. Srini Pharmaceuticals Company Information
Table 128. Srini Pharmaceuticals Introduction and Business Overview
Table 129. Srini Pharmaceuticals Sofosbuvir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 130. Srini Pharmaceuticals Sofosbuvir API Product Offerings
Table 131. Srini Pharmaceuticals Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Sofosbuvir API Downstream Customers
Table 135. Sofosbuvir API Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Sofosbuvir API Product Picture
Figure 2. Global Sofosbuvir API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Sofosbuvir API Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Sofosbuvir API Sales Volume (2020-2031) & (Kg)
Figure 5. Global Sofosbuvir API Sales Price (2020-2031) & (US$/Kg)
Figure 6. Sofosbuvir API Report Years Considered
Figure 7. Global Sofosbuvir API Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Sofosbuvir API Players Sales Volume Ranking (2024) & (Kg)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sofosbuvir API Revenue in 2024
Figure 10. Sofosbuvir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Above 98 % Picture
Figure 12. Above 99 % Picture
Figure 13. Global Sofosbuvir API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Sofosbuvir API Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Sofosbuvir API Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
Figure 16. Global Sofosbuvir API Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Sofosbuvir API Price by Type (2020-2031) & (US$/Kg)
Figure 18. Product Picture of Tablets
Figure 19. Product Picture of Others
Figure 20. Global Sofosbuvir API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Sofosbuvir API Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Sofosbuvir API Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
Figure 23. Global Sofosbuvir API Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Sofosbuvir API Price by Application (2020-2031) & (US$/Kg)
Figure 25. North America Sofosbuvir API Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Sofosbuvir API Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Sofosbuvir API Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Sofosbuvir API Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Sofosbuvir API Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Sofosbuvir API Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Sofosbuvir API Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Sofosbuvir API Sales Volume (%), (2020-2031)
Figure 37. United States Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Sofosbuvir API Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Sofosbuvir API Sales Value by Application (%), 2024 VS 2031
Figure 43. China Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
Figure 45. China Sofosbuvir API Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Sofosbuvir API Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Sofosbuvir API Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Sofosbuvir API Sales Value by Application (%), 2024 VS 2031
Figure 55. India Sofosbuvir API Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Sofosbuvir API Sales Value by Type (%), 2024 VS 2031
Figure 57. India Sofosbuvir API Sales Value by Application (%), 2024 VS 2031
Figure 58. Sofosbuvir API Industrial Chain
Figure 59. Sofosbuvir API Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Sofosbuvir API market?
The top companies in the global Sofosbuvir API market are Mylan、Teva、Century Pharmaceuticals.
Related Reports
Sofosbuvir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sofosbuvir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
Global Sofosbuvir API Market Research Report 2026
The global Sofosbuvir API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 139
USD 2900.00
(Single User License)
Global Sofosbuvir API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sofosbuvir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 99
USD 4250.00
(Single User License)
Global Sofosbuvir API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sofosbuvir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 151
USD 4900.00
(Single User License)
Global Sofosbuvir API Market Research Report 2025
The global market for Sofosbuvir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 96
USD 2900.00
(Single User License)
Global Sofosbuvir API Market Research Report 2024
Sofosbuvir(CAS：1190307-88-0) is a medication used to treat hepatitis C.
Published Date: 2024-02-07
Pages: 121
USD 2900.00
(Single User License)
Sofosbuvir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sofosbuvir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 139
USD 3950.00 (Single User License)Global Sofosbuvir API Market Research Report 2026
The global Sofosbuvir API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 139
USD 2900.00 (Single User License)Global Sofosbuvir API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sofosbuvir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 99
USD 4250.00 (Single User License)Global Sofosbuvir API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sofosbuvir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 151
USD 4900.00 (Single User License)Global Sofosbuvir API Market Research Report 2025
The global market for Sofosbuvir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 96
USD 2900.00 (Single User License)Global Sofosbuvir API Market Research Report 2024
Sofosbuvir(CAS：1190307-88-0) is a medication used to treat hepatitis C.
Published: 2024-02-07
Pages: 121
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now